Industry Press Releases

Technical Reports on Specialty Chemicals Equities -- International Flavors & Fragrances, PolyOne, TerraVia, and Valspar

Friday, Dec 30, 2016 takes a look at some Specialty Chemicals equities to see how they have fared over the last few trading sessions. Under review today are: International Flavors & Fragrances Inc. (NYSE: IFF), PolyOne Corp. (NYSE: POL), TerraVia Holdings Inc. (NASDAQ: TVIA), and The Valspar Corp. (NYSE: VAL). According to a report by the American Chemistry Council, US Specialty Chemicals market volumes rose 0.4% in November, following a revised 0.1% gain in October and a 0.2% gain in September. Volumes have generally been moving up since May. Today's research reports on the aforementioned stocks are downloadable for free upon registration at:

International Flavors & Fragrances  

New York-based International Flavors & Fragrances Inc.'s stock finished Wednesday's session 0.18% lower at $118.80 with a total trading volume of 404,754 shares. Since the start of this year, the Company's shares have advanced 1.23%. The stock is trading below its 50-day moving average by 3.52%. Moreover, shares of International Flavors & Fragrances, which together with its subsidiaries, creates, manufactures, and supplies flavors and fragrances for use in consumer products, have a Relative Strength Index (RSI) of 41.93.

On December 14th, 2016, the Company announced that its Board of Directors has declared a regular quarterly cash dividend of $0.64 per share of its common stock, payable on January 6th, 2017 to shareholders of record as of December 28th, 2016. Visit us today and access our complete research report on IFF at:


Shares in Avon Lake, Ohio headquartered PolyOne Corp. declined 3.03%, ending yesterday's session at $32.31 with a total trading volume of 302,419 shares. The stock has gained 3.28% on an YTD basis. The Company's shares are trading 1.12% above their 50-day moving average. Moreover, shares of PolyOne, which provides specialized polymer materials, services, and solutions with operations in specialty polymer formulations, color and additive systems, plastic sheet and packaging solutions, and polymer distribution, have an RSI of 45.46. The complimentary report on POL can be downloaded at:


On Wednesday, South San Francisco, California headquartered TerraVia Holdings Inc.'s stock saw a drop of 8.70%, to close the day at $1.05. A total volume of 1.05 million shares was traded, which was above their three months average volume of 789,640 shares. The Company's shares are trading 37.97% below their 50-day moving average. Additionally, shares of TerraVia Holdings, which creates and sells food, nutrition, and specialty ingredients from algae, have an RSI of 37.28.

On December 21st, 2016, TerraVia Holdings announced that on December 20th, 2016, the US Court of Appeals for the Third Circuit issued a decision in the appeal by Roquette Frères, S.A. ("Roquette") of an arbitration award connected with the Solazyme Roquette Nutritionals, L.L.C. ("SRN") joint venture. The appeals court affirmed, without modification, the original arbitration award, which ordered the assignment to TerraVia of: All SRN patent applications. All SRN "know-how" related to high lipid algae flour and high protein algae powder. All Roquette patent applications filed since November 2010 relating to microalgal food and food ingredients, as well as methods for making and using them. In addition, the original arbitration award ordered Roquette to pay to TerraVia $2.3 million in legal costs and fees. Register for free on and access the latest research report on TVIA at:


Shares in Minneapolis, Minnesota headquartered The Valspar Corp. ended the day 0.01% higher at $103.51 with a total trading volume of 137,639 shares. The stock has gained 1.86% in the last one month and 26.54% since the start of this year. The Company's shares are trading above their 50-day moving average by 1.12%. Furthermore, shares of Valspar, which develops, manufactures, and distributes a range of coatings, paints, and related products worldwide, have an RSI of 63.99.

On December 20th, 2016, Valspar reported Q4 FY16 net sales of $1.11 billion compared to $1.15 billion for Q4 FY15. The Company's net income for Q4 FY16 came in at $103.59 million, or $1.27 per diluted share, compared to $102.36 million, or $1.26 per diluted share, for Q4 FY15. For FY16, Valspar reported net sales of $4.19 billion compared to $4.39 billion in FY15. The Company reported net income of $353.04 million, or $4.36 per diluted share, in FY16 versus $399.51 million, or $4.85 per diluted share, in FY15. Get free access to your research report on VAL at:

Stock Callers:

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

SC has not been compensated; directly or indirectly; for producing or publishing this document.


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number:  +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP



Other Press Releases